logo
  

Terex Slash FY Outlook

Connecticut-based machinery manufacturing company, Terex Corporation (TEX), has slashed its outlook for the full year. The company forecast earnings in the range of $2.75 to $2.85 per share for the full year. The prior outlook for earnings was in the range of $2.85 to $3.05. On average 15 analysts polled by Thomson Reuters currently expect earnings of $2.82 for the full year.

The company expects revenues to be $3.85 billion for the year, down from prior guidance of $3.90 billion. Analysts' estimate for revenue is $3.86 billion for the same period.

Chairman and Chief Executive Officer John L. Garrison, Jr. said, "We will close out the full year 2021 with a strong backlog, continued cost discipline, and positive free cash flow. We remain confident in our team's ability to manage through current market conditions and emerge with stronger customer and supplier relationships. We will continue our investments to enable longer-term growth."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Frozen Food Development is recalling specific lots of Lidl branded 12-ounce packages of Frozen Chopped Spinach citing the potential to be contaminated with Listeria monocytogenes, the U.S. Food and Drug Administration said. The product comes in 12-ounce poly bags, and items included in the recall are marked with lot # R17742 or R17963 on the back of the poly bag with a best by date of 09/10/23. Starbucks has dropped its vaccine or weekly test requirement against Covid-19 for U.S. employees in the wake of last week's U.S. Supreme Court ruling. The court, in a 6-3 vote, has blocked President Joe Biden's vaccine-or-test mandate for private companies with 100 or more employees. However, it allowed the vaccine mandate to stand for certain health care workers. Mylan Pharmaceuticals Inc., affiliated to healthcare company Viatris Inc., is recalling one batch of its non-interchangeable Semglee (insulin glargine injection), 100 units/ml (U-100), 3mL prefilled pens due to the potential for a missing label, the U.S. Food and Drug Administration said.
RELATED NEWS
Follow RTT